• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对输注法国热处理浓缩物的甲型和乙型血友病患者的临床与生物学调查。

Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.

作者信息

Parquet A, Boneu B, Bosser C, Cazenave J P, Dirat G, Gazengel G, Grunebaum L, Sultan Y, Verroust F, Wiesel M L

机构信息

Centre Régional de Transfusion Sanguine, Lille, France.

出版信息

Nouv Rev Fr Hematol (1978). 1988;30(4):205-7.

PMID:3143099
Abstract

The efficiency of heat treatment procedures of factor VIII and factor IX concentrates, prepared from voluntary, non-paid donors by three French Blood Transfusion Centres, on the inactivation of HIV and non-A, non-B hepatitis (NANB) viruses was assessed. Some 43 patients (26 haemophilia A, 17 haemophilia B) were followed for at least 1 year by testing for HIV antibodies and alanine aminotransferase (ALT). No HIV seroconversion was observed indicating that heat treatment was completely efficient. Among 26 haemophiliacs, 6 (4 haemophilia A, 2 haemophilia B) presented an elevation in ALT, indicating only a 75% reduction of NANB viral contamination.

摘要

对法国三个输血中心从自愿无偿献血者中采集制备的凝血因子VIII和凝血因子IX浓缩物的热处理程序在灭活HIV和非甲非乙型肝炎(NANB)病毒方面的效率进行了评估。通过检测HIV抗体和丙氨酸转氨酶(ALT),对约43名患者(26名甲型血友病患者、17名乙型血友病患者)进行了至少1年的随访。未观察到HIV血清转化,表明热处理完全有效。在26名血友病患者中,6名(4名甲型血友病患者、2名乙型血友病患者)ALT升高,表明NANB病毒污染仅减少了75%。

相似文献

1
Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.对输注法国热处理浓缩物的甲型和乙型血友病患者的临床与生物学调查。
Nouv Rev Fr Hematol (1978). 1988;30(4):205-7.
2
AIDS and haemophilia.
Biomed Pharmacother. 1985;39(7):355-65.
3
Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.法国血友病患者中的丙型肝炎抗体(抗C 100-3)
Nouv Rev Fr Hematol (1978). 1991;33(3):263-6.
4
[Hemophilia and HTLV-III infection].
Z Hautkr. 1986 Dec 1;61(23):1687-704.
5
[Current status of viral safety of virus inactivated factor VIII and IX concentrates in treatment of hemophilia].[病毒灭活的凝血因子VIII和IX浓缩物在血友病治疗中的病毒安全性现状]
Infusionsther Transfusionsmed. 1994 Aug;21 Suppl 1:80-3.
6
[Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].[在需要替代疗法的血友病患者中预防输血相关病毒感染]
Beitr Infusionsther. 1989;24:46-55.
7
[HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
Padiatr Padol. 1987;22(1):33-41.
8
AIDS and haemophilia.艾滋病与血友病。
Biomed Pharmacother. 1985;39(7):347-50.
9
Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.仅接受重组因子(F)VIII治疗或至少接受过一次血浆源性FVIII或FIX浓缩剂治疗的血友病儿童中抗人细小病毒B19 IgG抗体的患病率:来自法国血友病队列的结果
Br J Haematol. 2002 Feb;116(2):383-9.
10
Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.血友病患者中抗LAV/HTLV III抗体与使用病毒灭活凝血因子的相关性。
Thromb Haemost. 1986 Aug 20;56(1):50-2.